A novel ligand conjugated nanoparticles for oral insulin delivery

References

• Behrens I, Pena AIV, Alonso MJ, et al. (2002). Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport. Pharm Res 19:1185–93
   PubMed Web of Science ®Google Scholar
• Clark MA, Blair H, Liang L, et al. (2001). Targeting polymerised liposome vaccine carriers to intestinal M cells. Vaccine 20:208–17
   PubMed Web of Science ®Google Scholar
• Cui F, Shi K, Zhang L, et al. (2006). Biodegradable nanoparticles loaded with insulin–phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation. J Control Release 114:242–50
   PubMed Web of Science ®Google Scholar
• Du W, Fan Y, Zheng N, et al. (2013). Transferrin receptor specific nanocarriers conjugated with functional 7 peptide for oral drug delivery. Biomaterials 34:794–806
   PubMed Web of Science ®Google Scholar
• Frokjaer S, Otzen DE. (2005). Protein drug stability: a formulation challenge. Nat Rev Drug Discov 4:298–306
   PubMed Web of Science ®Google Scholar
• Garinot M, Fievez V, Pourcelle V, et al. (2007). PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination. J Control Release 120:195–204
   PubMed Web of Science ®Google Scholar
• Guo Z, He B, Jin H, et al. (2014). Targeting efficiency of RGD-modified nanocarriers with different ligand intervals in response to integrin αvβ3 clustering. Biomaterials 35:6106–17
   PubMed Web of Science ®Google Scholar
• Gupta S, Jain A, Chakraborty M, et al. (2013). Oral delivery of therapeutic proteins and peptides: a review on recent developments. Drug Deliv 20:237–46
   PubMed Web of Science ®Google Scholar
• Hsu L-W, Ho Y-C, Chuang E-Y, et al. (2013). Effects of pH on molecular mechanisms of chitosan–integrin interactions and resulting tight-junction disruptions. Biomaterials 34:784–93
   PubMed Web of Science ®Google Scholar
• Hu X, Yang F-F, Quan L-H, et al. (2014). Pulmonary delivered polymeric micelles – pharmacokinetic evaluation and biodistribution studies. Eur J Pharm Biopharm 88:1064–75
   PubMed Web of Science ®Google Scholar
• Huang A, Su Z, Li S, et al. (2014). Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers. Drug Deliv 21:388–96
   PubMed Web of Science ®Google Scholar
• Jin Y, Song Y, Zhu X, et al. (2012). Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport. Biomaterials 33:1573–82
   PubMed Web of Science ®Google Scholar
• Kang SK, Woo JH, Kim MK, et al. (2008). Identification of a peptide sequence that improves transport of macromolecules across the intestinal mucosal barrier targeting goblet cells. J Biotechnol 135:210–16
   PubMed Web of Science ®Google Scholar
• Kim H, Akagi T, Akashi M. (2009). Preparation of size tunable amphiphilic poly(amino acid) nanoparticles. Macromol Biosci 9:842–8
   PubMed Web of Science ®Google Scholar
• Kunisawa J, Kurashima Y, Kiyono H. (2012). Gut-associated lymphoid tissues for the development of oral vaccines. Adv Drug Deliv Rev 64:523–30
   PubMed Web of Science ®Google Scholar
• Lin YH, Sonaje K, Lin KM, et al. (2008). Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs. J Control Release 132:141–9
   PubMed Web of Science ®Google Scholar
• Liu H, Gong T, Fu HL, et al. (2008). Solid lipid nanoparticles for pulmonary delivery of insulin. Int J Pharm 356:333–44
   PubMed Web of Science ®Google Scholar
• Makhlof A, Tozuka Y, Takeuchi H. (2011). Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Eur J Pharm Sci 42:445–51
   PubMed Web of Science ®Google Scholar
• Mo R, Jin X, Li N, et al. (2011). The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles. Biomaterials 32:4609–20
   PubMed Web of Science ®Google Scholar
• Nakase I, Niwa M, Takeuchi T, et al. (2004). Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol Ther 10:1011–22
   PubMed Web of Science ®Google Scholar
• Peppas NA, Kavimandan NJ. (2006). Nanoscale analysis of protein peptide absorption: insulin absorption using complexation and pH-sensitive hydrogels as delivery vehicles. Eur J Pharm Sci 29:183–97
   PubMed Web of Science ®Google Scholar
• Rekha MR, Sharma CP. (2009). Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption. J Control Release 135:144–51
   PubMed Web of Science ®Google Scholar
• Russell-Jones GJ. (2001). The potential use of receptor-mediated endocytosis for oral drug delivery. Adv Drug Deliv Rev 46:59–73
   PubMed Web of Science ®Google Scholar
• Sadeghi AMM, Dorkoosh FA, Avadi MR, et al. (2008). Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells. Eur J Pharm Biopharm 70:270–8
   PubMed Web of Science ®Google Scholar
• Sajeesh S, Bouchemal K, Marsaud V, et al. (2010). Cyclodextrin complexed insulin encapsulated hydrogel microparticles: an oral delivery system for insulin. J Control Release 147:377–84
   PubMed Web of Science ®Google Scholar
• Shan W, Zhu X, Liu M, et al. (2015). Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin. ACS Nano 9:2345–56
   PubMed Web of Science ®Google Scholar
• Suzuki A, Morishita M, Kajita M, et al. (1998). Enhanced colonic and rectal absorption of insulin using a multiple emulsion containing eicosapentaenoic acid and docosahexaenoic acid. J Pharm Sci 87:1196–202
   PubMed Web of Science ®Google Scholar
• Svensen N, Diaz-Mochon JJ, Bradley M. (2011). Decoding a PNA encoded peptide library by PCR: the discovery of new cell surface receptor ligands. Chem Biol 18:1284–9
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Pardakhty A, Hajhashemi V-I, et al. (2003). Development and physical characterization of sorbitan monoester niosomes for insulin oral delivery. Drug Deliv 10:251–62
   PubMed Web of Science ®Google Scholar
• Wang X-Q, Zhang Q. (2012). pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs. Eur J Pharm Biopharm 82:219–29
   PubMed Web of Science ®Google Scholar
• Yoo M-K, Kang S-K, Choi J-H, et al. (2010). Targeted delivery of chitosan nanoparticles to Peyer's patch using M cell-homing peptide selected by phage display technique. Biomaterials 31:7738–47
   PubMed Web of Science ®Google Scholar
• Yun Y, Cho YW, Park K. (2013). Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery. Adv Drug Deliv Rev 65:822–32
   PubMed Web of Science ®Google Scholar
• Zhang J, Ma PX. (2009). Polymeric core–shell assemblies mediated by host–guest interactions: versatile nanocarriers for drug delivery. Angew Chem Int Ed 48:964–8
   PubMed Web of Science ®Google Scholar
• Zhang N, Ping QN, Huang GH, et al. (2005). Investigation of lectin-modified insulin liposomes as carriers for oral administration. Int J Pharm 294:247–59
   PubMed Web of Science ®Google Scholar
• Zhang XW, Qi JP, Lu Y, et al. (2014a). Biotinylated liposomes as potential carriers for the oral delivery of insulin. Nanomed Nanotechnol 10:167–76
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhu X, Jin Y, et al. (2014b). Mechanism study of cellular uptake and tight junction opening mediated by goblet cell-specific trimethyl chitosan nanoparticles. Mol Pharm 11:1520–32
   PubMed Web of Science ®Google Scholar